NEWS & MEDIA

Ultime News

Mastrodonato (BMG Pharma): senza innovazione non si può avere successo

Mastrodonato (BMG Pharma): senza innovazione non si può avere successo

Are you interested in knowing the point of view of our founder and CEO Marco Mastrodonato about how to do pharmaceutical entrepreneurship?

Read his interview on Caltalks:
“Thinking outside the box “, the innovation as secret of the success.
BMG Pharma performs the concept of innovation in the biotech sector, relying on chemical structure modification of biotechnological origin for the development of new chemical entities and improving their functions and efficacy, differentiating itself from all competitors on the market. “Our strategy,” Mastrodonato continues, “is to develop biotechnology products covering both aesthetic dermatology and osteoarthritis.”
In BMG Pharma we find not limits, but solutions, the company wants to be present in the market bringing new products based on science and aligning itself with an evolving context, trying to deliver in the hands of the physician something truly innovative, interactive, and effective to propose to the patient.

To read the whole interview, click here: https://www.caltalks.com/2023/11/mastrodonato-bmg-pharma-senza.html

BMG Pharma lancia la nuova tecnologia “Hyaluromimethic”

BMG Pharma lancia la nuova tecnologia “Hyaluromimethic”

Dal 2011, BMG Pharma è un’eccellenza italiana a servizio del settore biotecnologico, che sta apportando grandi novità nel settore dei biopolimeri.
Segui l’intervista del Sole24Ore al nostro CEO Marco Mastrodonato riguardo alla nuova piattaforma tecnologica Hyaluromimethic ® ad ai progetti in sviluppo.

BMG Pharma
We Make it Happen

Eventi

Mastrodonato (BMG Pharma): senza innovazione non si può avere successo

Mastrodonato (BMG Pharma): senza innovazione non si può avere successo

Are you interested in knowing the point of view of our founder and CEO Marco Mastrodonato about how to do pharmaceutical entrepreneurship?

Read his interview on Caltalks:
“Thinking outside the box “, the innovation as secret of the success.
BMG Pharma performs the concept of innovation in the biotech sector, relying on chemical structure modification of biotechnological origin for the development of new chemical entities and improving their functions and efficacy, differentiating itself from all competitors on the market. “Our strategy,” Mastrodonato continues, “is to develop biotechnology products covering both aesthetic dermatology and osteoarthritis.”
In BMG Pharma we find not limits, but solutions, the company wants to be present in the market bringing new products based on science and aligning itself with an evolving context, trying to deliver in the hands of the physician something truly innovative, interactive, and effective to propose to the patient.

To read the whole interview, click here: https://www.caltalks.com/2023/11/mastrodonato-bmg-pharma-senza.html

BMG Pharma lancia la nuova tecnologia “Hyaluromimethic”

BMG Pharma lancia la nuova tecnologia “Hyaluromimethic”

Dal 2011, BMG Pharma è un’eccellenza italiana a servizio del settore biotecnologico, che sta apportando grandi novità nel settore dei biopolimeri.
Segui l’intervista del Sole24Ore al nostro CEO Marco Mastrodonato riguardo alla nuova piattaforma tecnologica Hyaluromimethic ® ad ai progetti in sviluppo.

BMG Pharma
We Make it Happen

Ultime News

Mastrodonato (BMG Pharma): senza innovazione non si può avere successo

Mastrodonato (BMG Pharma): senza innovazione non si può avere successo

Are you interested in knowing the point of view of our founder and CEO Marco Mastrodonato about how to do pharmaceutical entrepreneurship?

Read his interview on Caltalks:
“Thinking outside the box “, the innovation as secret of the success.
BMG Pharma performs the concept of innovation in the biotech sector, relying on chemical structure modification of biotechnological origin for the development of new chemical entities and improving their functions and efficacy, differentiating itself from all competitors on the market. “Our strategy,” Mastrodonato continues, “is to develop biotechnology products covering both aesthetic dermatology and osteoarthritis.”
In BMG Pharma we find not limits, but solutions, the company wants to be present in the market bringing new products based on science and aligning itself with an evolving context, trying to deliver in the hands of the physician something truly innovative, interactive, and effective to propose to the patient.

To read the whole interview, click here: https://www.caltalks.com/2023/11/mastrodonato-bmg-pharma-senza.html

BMG Pharma lancia la nuova tecnologia “Hyaluromimethic”

BMG Pharma lancia la nuova tecnologia “Hyaluromimethic”

Dal 2011, BMG Pharma è un’eccellenza italiana a servizio del settore biotecnologico, che sta apportando grandi novità nel settore dei biopolimeri.
Segui l’intervista del Sole24Ore al nostro CEO Marco Mastrodonato riguardo alla nuova piattaforma tecnologica Hyaluromimethic ® ad ai progetti in sviluppo.

BMG Pharma
We Make it Happen